Video Library

Current Advances in Hepatobiliary and Pancreatic Disease

Aired on 2.19.2016
FREE
Current Advances in Hepatobiliary and Pancreatic Disease
The Physician Engagement Education Series brings healthcare providers together from around the world to discuss and share ideas on current and cutting edge concepts in medicine through interactive broadcasts. The interactive format includes case presentations and discussion by key opinion leaders from around the world with audience and faculty interaction, discussion, polling and debate. The live broadcasts are recorded and available online for healthcare providers to review even after the live event. Price: $180.00 to attend for CME.

Description

This course will focus upon current concepts, diagnosis and therapy for benign and malignant conditions of the hepato-biliary system and pancreas. Discussions regarding management of straight forward and complicated cases will form the core of the core, with the presentation of new and evolving modalities for diagnosis and treatment.

Directors & Faculty

Directors

Jeffrey Ponsky, MD

Jeffrey L. Ponsky joined The Cleveland Clinic as the Director of Endoscopic Surgery and was their first Executive Director of the Minimally Invasive Surgery Center.  In 2005 he assumed the Oliver H. Payne Professorship and Chair of the Department of Surgery at Case Western University School of Medicine and University Hospitals of Cleveland.  Dr. Ponsky served as Surgeon-in-Chief at University Hospitals Case Medical Center. Currently, after a 9.5 year hiatus, he has returned to the Cleveland Clinic as a senior staff surgeon in both GI and General Surgery. In addition, he holds a half time leadership appointment in the Office of Patient Experience. 

Matthew Walsh, MD, FACS

Matthew Walsh is currently Chairman of General Surgery at the Cleveland Clinic in Cleveland, Ohio.  He came to Cleveland originally to train in HPB surgery with Robert Hermann, prior Chair of the Department of General Surgery.  He continued in the Department as faculty for the balance of his career, rising to Professor of Surgery at CWRU and awarded the Rich Family Distinguished Chair in Digestive Diseases.  His interests lie in pancreatic surgery, minimally invasive surgery, endoscopy and education.  He has been honored with several teaching awards including the highest teaching excellence awards of the Ohio State University and Case Western Reserve University.  Originally from Green Bay, Wisconsin he attended college in Nebraska and medical school in Wisconsin.  His surgery residency was at Loyola University of Chicago and at Massachusetts General Hospital prior to his HPB Fellowship.


Additional Faculty

Prabhleen Chahal, MD, FASGE, FACG


Expert in advance endoscopic techniques for management of pancreas and biliary diseases. Trained at Mayo Clinic Rochester, MN.  Practicing as an advance endoscopic staff since 8 years.  Over 35 publications in peer reviewed journals.  Involved in national gastroenterology and endoscopy society committees, courses and post graduate courses.  

Eren Berber, MD

He is a Professor of Surgery at the Cleveland Clinic, and currently is the director of Robotic Endocrine Surgery and co-director of Multidisciplinary Liver Tumor Clinic.  His areas of interest include laparoscopic and robotic liver surgery, laparoscopic liver tumor ablation, robotic surgery, conventional and minimally invasive endocrine surgery (thyroid, parathyroid, adrenal and pancreas), robotic thyroidectomy, robotic adrenalectomy and surgical ultrasound.  He serves on the editorial boards of Surgical Laparoscopy & Endoscopy, Videoendocrinology, and Journal of Surgical Oncology. He is an active member of numerous surgical societies, and serves on multiple committees.  He is the past president of Clinical Robotic Surgery Association (CRSA).

Tyler Stevens, MD

Dr. Stevens is a staff gastroenterologist at the main campus and an assistant professor in the Cleveland Clinic Lerner College of Medicine. He completed his residency and fellowship training at the Cleveland Clinic. He has a clinical and research interest in pancreatic diseases.

Cristiano Quintini, MD

Dr. Quintini currently holds the academic title Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. Dr. Quintini has focused his clinical research in ways to improve the number of liver transplants performed and to improve outcomes after transplant. Dr. Quintini, 4 years ago initiated an ex-vivo organ perfusion translational lab to investigate the principles behind liver, kidney, intestine, pancreas and limb using this innovative preservation technology. This research culminated in the first FDA approved (IDE) clinical liver ex-vivo normothermic machine perfusion device for a liver perfusion clinical trial, expected to start January 2016. For the first time he showed the potential regeneration potential of ex-vivo liver perfusion. 

Charles Miller, MD

Charles Miller, MD, is the Director of Liver Transplantation in the Transplantation Center at Cleveland Clinic. Liver transplantation and living donation are his areas of special interest.  Dr. Miller is also a Staff Physician in the Department of General Surgery and Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Previously, he was the Alfred and Florence Gross Professor of Surgery at the Mount Sinai School of Medicine.  Recently, he was honored by the Mount Sinai School of Medicine with the creation of the School’s Charles M. Miller MD Distinguished Professorship in Transplant Surgery.  Dr. Miller has been actively involved for over twenty years in the leadership of the American Society of Transplant Surgeons, currently serving as President.  Among other roles, he served previously as Chair and Co-chair of the ASTS Ethics Committee, Chair of the Education Committee, Counselor at Large and Secretary of the organization. 

Gareth Morris-Stiff, MB BCh, MD, MCh, PhD, FRCS

Staff HPB Surgeon Cleveland Clinic Foundation & Associate Professor Lerner College of Medicine at Case Western Reserve University, Dr Morris-Stiff graduated from the University of Wales College of Medicine in 1992 earing his medical degree (MBBCh). He obtained his FRCS in 1997 and chose the speciality of hepato-pancreatico-biliary (HPB) surgery as his clinical domain. He has trained in HPB and laparoscopic surgery in Cardiff (Wales) as well as Birmingham and Leeds (England), and also undertook a prestigious American HPB Association Clinical Fellowship in HPB Surgery at the Cleveland Clinic, Cleveland, Ohio. 

Sricharan Chalikonda, MD, MHA, FACS

Sricharan (Sri) Chalikonda, MD, MHA, FACS. is the Chairman of Surgical Operations, a staff surgeon in the Digestive Disease Institute and currently serves as both the Associate Program Director for the General Surgery Residency Program and Director of Robotic Surgery.  Dr. Chalikonda has been elected to serve on the CCF Board of Governors and the Medical Executive Committee His specialty interests include Surgical Oncology, General Surgery, and Laparoscopic Surgery.  He returned to Cleveland after his training for a fellowship in Minimally Invasive & Bariatric Surgery before joining the staff in 2009 as the Director of Robotic Surgery and Director of the Peritoneal Surface Malignancy Program. A surgical innovator, Dr. Chalikonda performed the organization’s first robotic Whipple procedure and the first HIPEC (Hyperthermic Chemotherapy) for carcinomatosis. 

Agenda

9:00 am - 10:05 am
Cystic Lesions of Pancreas




10:05 am - 10:15 am
Break
10:15 am - 11:20 am
Pseudocyst and Necrosis of Pancreas




11:20 am - 11:30 am
Break
11:30 am - 12:35 pm
Pancreatic Cancer




12:35 pm - 1:05 pm
Lunch
1:05 pm - 2:10 pm
Cholangiocarcinoma






2:10 pm - 2:20 pm
Break
2:20 pm - 3:25 pm
Hepatocellular Cancer






3:25 pm - 3:30 pm
Closing Remarks

Topics Covered

  • Pancreatic Cancer
  • Cholangiocarcinoma
  • Hepatocellular Carcinomas
  • Cystic Lesions of Pancreas
  • Pseudocyst and Necrosis of Pancreas

Objectives

  1. To inform the audience regarding current concepts in the diagnosis and management of hepato-billary and pancreatic disease.
  2. To introduce newer and evolving modalities of therapy for disease of the biliary tree and pancreas.
  3. To involve the audience in case discussions and the synthesis of treatment plans for complicated hepatobiliary and pancreatic cases.
Host

Show Disclosure